001     167135
005     20240917142802.0
024 7 _ |a 10.1056/NEJMoa1913948
|2 doi
024 7 _ |a pmid:33471991
|2 pmid
024 7 _ |a 0028-4793
|2 ISSN
024 7 _ |a 1533-4406
|2 ISSN
024 7 _ |a altmetric:98052114
|2 altmetric
037 _ _ |a DKFZ-2021-00156
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Consortium, Breast Cancer Association
|b 0
|e Collaboration Author
245 _ _ |a Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women.
260 _ _ |a Waltham, Mass.
|c 2021
|b MMS
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1726576057_13460
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2021 Feb 4;384(5):428-439
520 _ _ |a Genetic testing for breast cancer susceptibility is widely used, but for many genes, evidence of an association with breast cancer is weak, underlying risk estimates are imprecise, and reliable subtype-specific risk estimates are lacking.We used a panel of 34 putative susceptibility genes to perform sequencing on samples from 60,466 women with breast cancer and 53,461 controls. In separate analyses for protein-truncating variants and rare missense variants in these genes, we estimated odds ratios for breast cancer overall and tumor subtypes. We evaluated missense-variant associations according to domain and classification of pathogenicity.Protein-truncating variants in 5 genes (ATM, BRCA1, BRCA2, CHEK2, and PALB2) were associated with a risk of breast cancer overall with a P value of less than 0.0001. Protein-truncating variants in 4 other genes (BARD1, RAD51C, RAD51D, and TP53) were associated with a risk of breast cancer overall with a P value of less than 0.05 and a Bayesian false-discovery probability of less than 0.05. For protein-truncating variants in 19 of the remaining 25 genes, the upper limit of the 95% confidence interval of the odds ratio for breast cancer overall was less than 2.0. For protein-truncating variants in ATM and CHEK2, odds ratios were higher for estrogen receptor (ER)-positive disease than for ER-negative disease; for protein-truncating variants in BARD1, BRCA1, BRCA2, PALB2, RAD51C, and RAD51D, odds ratios were higher for ER-negative disease than for ER-positive disease. Rare missense variants (in aggregate) in ATM, CHEK2, and TP53 were associated with a risk of breast cancer overall with a P value of less than 0.001. For BRCA1, BRCA2, and TP53, missense variants (in aggregate) that would be classified as pathogenic according to standard criteria were associated with a risk of breast cancer overall, with the risk being similar to that of protein-truncating variants.The results of this study define the genes that are most clinically useful for inclusion on panels for the prediction of breast cancer risk, as well as provide estimates of the risks associated with protein-truncating variants, to guide genetic counseling. (Funded by European Union Horizon 2020 programs and others.).
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Dorling, Leila
|b 1
700 1 _ |a Carvalho, Sara
|b 2
700 1 _ |a Allen, Jamie
|b 3
700 1 _ |a González-Neira, Anna
|b 4
700 1 _ |a Luccarini, Craig
|b 5
700 1 _ |a Wahlström, Cecilia
|b 6
700 1 _ |a Pooley, Karen A
|b 7
700 1 _ |a Parsons, Michael T
|b 8
700 1 _ |a Fortuno, Cristina
|b 9
700 1 _ |a Wang, Qin
|b 10
700 1 _ |a Bolla, Manjeet K
|b 11
700 1 _ |a Dennis, Joe
|b 12
700 1 _ |a Keeman, Renske
|0 0000-0002-5452-9933
|b 13
700 1 _ |a Alonso, M Rosario
|b 14
700 1 _ |a Álvarez, Nuria
|b 15
700 1 _ |a Herraez, Belen
|b 16
700 1 _ |a Fernandez, Victoria
|b 17
700 1 _ |a Núñez-Torres, Rocio
|b 18
700 1 _ |a Osorio, Ana
|b 19
700 1 _ |a Valcich, Jeanette
|b 20
700 1 _ |a Li, Minerva
|b 21
700 1 _ |a Törngren, Therese
|b 22
700 1 _ |a Harrington, Patricia A
|b 23
700 1 _ |a Baynes, Caroline
|b 24
700 1 _ |a Conroy, Don M
|b 25
700 1 _ |a Decker, Brennan
|0 0000-0003-4516-7421
|b 26
700 1 _ |a Fachal, Laura
|b 27
700 1 _ |a Mavaddat, Nasim
|b 28
700 1 _ |a Ahearn, Thomas
|b 29
700 1 _ |a Aittomäki, Kristiina
|b 30
700 1 _ |a Antonenkova, Natalia N
|b 31
700 1 _ |a Arnold, Norbert
|b 32
700 1 _ |a Arveux, Patrick
|b 33
700 1 _ |a Ausems, Margreet G E M
|b 34
700 1 _ |a Auvinen, Päivi
|b 35
700 1 _ |a Becher, Heiko
|b 36
700 1 _ |a Beckmann, Matthias W
|b 37
700 1 _ |a Behrens, Sabine
|b 38
700 1 _ |a Bermisheva, Marina
|b 39
700 1 _ |a Białkowska, Katarzyna
|b 40
700 1 _ |a Blomqvist, Carl
|b 41
700 1 _ |a Bogdanova, Natalia V
|b 42
700 1 _ |a Bogdanova-Markov, Nadja
|b 43
700 1 _ |a Bojesen, Stig E
|b 44
700 1 _ |a Bonanni, Bernardo
|b 45
700 1 _ |a Børresen-Dale, Anne-Lise
|b 46
700 1 _ |a Brauch, Hiltrud
|0 P:(DE-HGF)0
|b 47
700 1 _ |a Bremer, Michael
|b 48
700 1 _ |a Briceno, Ignacio
|b 49
700 1 _ |a Brüning, Thomas
|b 50
700 1 _ |a Burwinkel, Barbara
|0 P:(DE-He78)15b7fd2bc02d5ef47a2fe2dd0140d2bf
|b 51
700 1 _ |a Cameron, David A
|b 52
700 1 _ |a Camp, Nicola J
|b 53
700 1 _ |a Campbell, Archie
|b 54
700 1 _ |a Carracedo, Angel
|b 55
700 1 _ |a Castelao, Jose E
|b 56
700 1 _ |a Cessna, Melissa H
|b 57
700 1 _ |a Chanock, Stephen J
|b 58
700 1 _ |a Christiansen, Hans
|b 59
700 1 _ |a Collée, J Margriet
|b 60
700 1 _ |a Cordina-Duverger, Emilie
|b 61
700 1 _ |a Cornelissen, Sten
|b 62
700 1 _ |a Czene, Kamila
|b 63
700 1 _ |a Dörk, Thilo
|b 64
700 1 _ |a Ekici, Arif B
|b 65
700 1 _ |a Engel, Christoph
|b 66
700 1 _ |a Eriksson, Mikael
|0 0000-0001-8135-4270
|b 67
700 1 _ |a Fasching, Peter A
|b 68
700 1 _ |a Figueroa, Jonine
|b 69
700 1 _ |a Flyger, Henrik
|b 70
700 1 _ |a Försti, Asta
|0 P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696
|b 71
700 1 _ |a Gabrielson, Marike
|b 72
700 1 _ |a Gago-Dominguez, Manuela
|b 73
700 1 _ |a Georgoulias, Vassilios
|b 74
700 1 _ |a Gil, Fabian
|b 75
700 1 _ |a Giles, Graham G
|b 76
700 1 _ |a Glendon, Gord
|b 77
700 1 _ |a Garcia, Encarna B Gómez
|b 78
700 1 _ |a Alnæs, Grethe I Grenaker
|b 79
700 1 _ |a Guénel, Pascal
|b 80
700 1 _ |a Hadjisavvas, Andreas
|b 81
700 1 _ |a Haeberle, Lothar
|b 82
700 1 _ |a Hahnen, Eric
|b 83
700 1 _ |a Hall, Per
|b 84
700 1 _ |a Hamann, Ute
|0 P:(DE-He78)537e07b3e57b16c7b214fc2242e4326b
|b 85
700 1 _ |a Harkness, Elaine F
|b 86
700 1 _ |a Hartikainen, Jaana M
|b 87
700 1 _ |a Hartman, Mikael
|b 88
700 1 _ |a He, Wei
|b 89
700 1 _ |a Heemskerk-Gerritsen, Bernadette A M
|b 90
700 1 _ |a Hillemanns, Peter
|b 91
700 1 _ |a Hogervorst, Frans B L
|b 92
700 1 _ |a Hollestelle, Antoinette
|b 93
700 1 _ |a Ho, Weang Kee
|b 94
700 1 _ |a Hooning, Maartje J
|b 95
700 1 _ |a Howell, Anthony
|b 96
700 1 _ |a Humphreys, Keith
|b 97
700 1 _ |a Idris, Faiza
|b 98
700 1 _ |a Jakubowska, Anna
|b 99
700 1 _ |a Jung, Audrey
|b 100
700 1 _ |a Kapoor, Pooja Middha
|b 101
700 1 _ |a Kerin, Michael J
|b 102
700 1 _ |a Khusnutdinova, Elza
|b 103
700 1 _ |a Kim, Sung-Won
|b 104
700 1 _ |a Ko, Yon-Dschun
|b 105
700 1 _ |a Kosma, Veli-Matti
|b 106
700 1 _ |a Kristensen, Vessela N
|b 107
700 1 _ |a Kyriacou, Kyriacos
|b 108
700 1 _ |a Lakeman, Inge M M
|b 109
700 1 _ |a Lee, Jong Won
|b 110
700 1 _ |a Lee, Min Hyuk
|b 111
700 1 _ |a Li, Jingmei
|b 112
700 1 _ |a Lindblom, Annika
|b 113
700 1 _ |a Lo, Wing-Yee
|b 114
700 1 _ |a Loizidou, Maria A
|b 115
700 1 _ |a Lophatananon, Artitaya
|b 116
700 1 _ |a Lubiński, Jan
|b 117
700 1 _ |a MacInnis, Robert J
|b 118
700 1 _ |a Madsen, Michael J
|b 119
700 1 _ |a Mannermaa, Arto
|b 120
700 1 _ |a Manoochehri, Mehdi
|b 121
700 1 _ |a Manoukian, Siranoush
|b 122
700 1 _ |a Margolin, Sara
|b 123
700 1 _ |a Martinez, Maria Elena
|0 0000-0002-6728-1834
|b 124
700 1 _ |a Maurer, Tabea
|b 125
700 1 _ |a Mavroudis, Dimitrios
|b 126
700 1 _ |a McLean, Catriona
|b 127
700 1 _ |a Meindl, Alfons
|b 128
700 1 _ |a Mensenkamp, Arjen R
|b 129
700 1 _ |a Michailidou, Kyriaki
|b 130
700 1 _ |a Miller, Nicola
|b 131
700 1 _ |a Mohd Taib, Nur Aishah
|b 132
700 1 _ |a Muir, Kenneth
|b 133
700 1 _ |a Mulligan, Anna Marie
|b 134
700 1 _ |a Nevanlinna, Heli
|b 135
700 1 _ |a Newman, William G
|b 136
700 1 _ |a Nordestgaard, Børge G
|b 137
700 1 _ |a Ng, Pei-Sze
|b 138
700 1 _ |a Oosterwijk, Jan C
|b 139
700 1 _ |a Park, Sue K
|b 140
700 1 _ |a Park-Simon, Tjoung-Won
|b 141
700 1 _ |a Perez, Jose I A
|b 142
700 1 _ |a Peterlongo, Paolo
|b 143
700 1 _ |a Porteous, David J
|b 144
700 1 _ |a Prajzendanc, Karolina
|b 145
700 1 _ |a Prokofyeva, Darya
|b 146
700 1 _ |a Radice, Paolo
|b 147
700 1 _ |a Rashid, Muhammad U
|b 148
700 1 _ |a Rhenius, Valerie
|b 149
700 1 _ |a Rookus, Matti A
|b 150
700 1 _ |a Rüdiger, Thomas
|b 151
700 1 _ |a Saloustros, Emmanouil
|b 152
700 1 _ |a Sawyer, Elinor J
|b 153
700 1 _ |a Schmutzler, Rita K
|b 154
700 1 _ |a Schneeweiss, Andreas
|b 155
700 1 _ |a Schürmann, Peter
|b 156
700 1 _ |a Shah, Mitul
|b 157
700 1 _ |a Sohn, Christof
|b 158
700 1 _ |a Southey, Melissa C
|b 159
700 1 _ |a Surowy, Harald
|b 160
700 1 _ |a Suvanto, Maija
|b 161
700 1 _ |a Thanasitthichai, Somchai
|b 162
700 1 _ |a Tomlinson, Ian
|b 163
700 1 _ |a Torres, Diana
|b 164
700 1 _ |a Truong, Thérèse
|b 165
700 1 _ |a Tzardi, Maria
|b 166
700 1 _ |a Valova, Yana
|b 167
700 1 _ |a van Asperen, Christi J
|b 168
700 1 _ |a Van Dam, Rob M
|b 169
700 1 _ |a van den Ouweland, Ans M W
|b 170
700 1 _ |a van der Kolk, Lizet E
|b 171
700 1 _ |a van Veen, Elke M
|b 172
700 1 _ |a Wendt, Camilla
|b 173
700 1 _ |a Williams, Justin A
|b 174
700 1 _ |a Yang, Xiaohong R
|b 175
700 1 _ |a Yoon, Sook-Yee
|b 176
700 1 _ |a Zamora, M Pilar
|b 177
700 1 _ |a Evans, D Gareth
|b 178
700 1 _ |a de la Hoya, Miguel
|b 179
700 1 _ |a Simard, Jacques
|b 180
700 1 _ |a Antoniou, Antonis C
|b 181
700 1 _ |a Borg, Åke
|b 182
700 1 _ |a Andrulis, Irene L
|b 183
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 184
700 1 _ |a García-Closas, Montserrat
|b 185
700 1 _ |a Chenevix-Trench, Georgia
|b 186
700 1 _ |a Milne, Roger L
|b 187
700 1 _ |a Pharoah, Paul D P
|0 0000-0001-8494-732X
|b 188
700 1 _ |a Schmidt, Marjanka K
|b 189
700 1 _ |a Spurdle, Amanda B
|b 190
700 1 _ |a Vreeswijk, Maaike P G
|b 191
700 1 _ |a Benitez, Javier
|b 192
700 1 _ |a Dunning, Alison M
|b 193
700 1 _ |a Kvist, Anders
|b 194
700 1 _ |a Teo, Soo H
|b 195
700 1 _ |a Devilee, Peter
|b 196
700 1 _ |a Easton, Douglas F
|b 197
773 _ _ |a 10.1056/NEJMoa1913948
|g p. NEJMoa1913948
|0 PERI:(DE-600)1468837-2
|n 5
|p 428-439
|t The New England journal of medicine
|v 384
|y 2021
|x 1533-4406
909 C O |p VDB
|o oai:inrepo02.dkfz.de:167135
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 47
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 51
|6 P:(DE-He78)15b7fd2bc02d5ef47a2fe2dd0140d2bf
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 71
|6 P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 85
|6 P:(DE-He78)537e07b3e57b16c7b214fc2242e4326b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 184
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
913 0 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-319H
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Addenda
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2020-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2020-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2020-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2020-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2020-11-17
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2020-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-11-17
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEW ENGL J MED : 2018
|d 2020-11-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2020-11-17
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2020-11-17
915 _ _ |a IF >= 70
|0 StatID:(DE-HGF)9970
|2 StatID
|b NEW ENGL J MED : 2018
|d 2020-11-17
920 1 _ |0 I:(DE-He78)C080-20160331
|k C080
|l Molekulare Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 1
920 1 _ |0 I:(DE-He78)B072-20160331
|k B072
|l Molekulargenetik des Mammakarzinoms
|x 2
920 1 _ |0 I:(DE-He78)B070-20160331
|k B070
|l B070 Funktionelle Genomanalyse
|x 3
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 4
920 1 _ |0 I:(DE-He78)TU01-20160331
|k TU01
|l DKTK Koordinierungsstelle Tübingen
|x 5
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C080-20160331
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a I:(DE-He78)B072-20160331
980 _ _ |a I:(DE-He78)B070-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)TU01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21